Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe

被引:82
作者
Tse, AN [1 ]
Schwartz, GK [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Gastrointestinal Oncol Res Lab, Div Solid Tumor Oncol, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1158/0008-5472.CAN-04-0841
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
UCN-01 is a potent inhibitor of the S- and G(2)-M-phase cell cycle checkpoints by targeting chk1 and possibly chk2 kinases. It has been shown in some, but not all, instances that UCN-01 potentiates the cytotoxicity of DNA-damaging agents selectively in p53-defective cells. We have investigated this concept in HCT 116 colon cancer cells treated with the topoisomerase I poison SN-38. SN-38 alone induced a senescence-like sustained G(2) arrest without apoptosis. Sequential treatment with SN-38 followed by UCN-01 resulted in enhancement of cytotoxicity by apoptosis assay, whereas the reverse sequence or concurrent treatment did not potentiate apoptosis. Real-time visualization of HCT116 cells labeled with green fluorescent protein-histone 213 or green fluorescent protein-alpha-tubulin revealed that sequential treatment resulted in G2 checkpoint abrogation, and cells entered an aberrant mitosis despite normal assembly of bipolar spindles, resulting in either apoptosis or formation of micro-nucleated cells. Although p53-null cells were clearly more sensitive than parental HCT116 to undergoing checkpoint abrogation and mitotic death after sequential treatment, this was not accompanied by an increased inhibition of clonogenicity over that induced by SN-38 alone. Conversely, concurrent treatment with SN-38 and UCN-01 resulted in S-phase checkpoint override, an amplified DNA damage response including increased phosphorylation of the DNA double-strand breakage marker H2AX and augmentation of clonogenic inhibition, which was independent of p53. Thus, reported discrepancies in the pharmacology of UCN-01 and the influence of p53 status on treatment outcome appears to stem, in part, from the different schedules used, the specific checkpoints examined, and the assays used to assess cytotoxicity. Moreover, checkpoint abrogation and subsequent apoptosis induced by UCN-01 do not necessarily correlate with reproductive cell death.
引用
收藏
页码:6635 / 6644
页数:10
相关论文
共 52 条
[1]   The p53-regulated cyclin-dependent kinase inhibitor, p21 (cip1, waf1, sdi1), is not required for global genomic and transcription-coupled nucleotide excision repair of UV-induced DNA photoproducts [J].
Adimoolam, S ;
Lin, CX ;
Ford, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :25813-25822
[2]   Questioning the role of checkpoint kinase 2 in the p53 DNA damage response [J].
Ahn, JW ;
Urist, M ;
Prives, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) :20480-20489
[3]  
Bunch RT, 1996, CLIN CANCER RES, V2, P791
[4]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[5]  
Busby EC, 2000, CANCER RES, V60, P2108
[6]   Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 [J].
Canman, CE ;
Lim, DS ;
Cimprich, KA ;
Taya, Y ;
Tamai, K ;
Sakaguchi, K ;
Appella, E ;
Kastan, MB ;
Siliciano, JD .
SCIENCE, 1998, 281 (5383) :1677-1679
[7]   Human BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at kinetochores and binds the cyclosome/APC [J].
Chan, GKT ;
Jablonski, SA ;
Sudakin, V ;
Hittle, JC ;
Yen, TJ .
JOURNAL OF CELL BIOLOGY, 1999, 146 (05) :941-954
[8]  
Chehab NH, 2000, GENE DEV, V14, P278
[9]   Dual mode of degradation of Cdc25 A phosphatase [J].
Donzelli, M ;
Squatrito, M ;
Ganoth, D ;
Hershko, A ;
Pagano, M ;
Draetta, GF .
EMBO JOURNAL, 2002, 21 (18) :4875-4884
[10]   The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways [J].
Falck, J ;
Petrini, JHJ ;
Williams, BR ;
Lukas, J ;
Bartek, J .
NATURE GENETICS, 2002, 30 (03) :290-294